This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cryopreservation method for Drosophila melanogaster embryos
Nature Communications Open Access 23 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rowley SD . Hematopoietic stem cell cryopreservation. In: Thomas ED, Storb R, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Scientific Inc: Malden, MA, USA, 1998, pp 481–492.
Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J . Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521–526.
Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705–4708.
Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533–537.
Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000; 25: 173–177.
Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA . Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994; 45: 187–188.
Hoyt R, Szer J, Grigg A . Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285–1287.
Higman MA, Port JD, Bezuchamp Jr NJ, Chen AR . Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26: 797–800.
Bawens D, Hantson P, Laterre PF, Michaux L, Latinne D, Tourtchaninoff M et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005; 46: 1671–1674.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Júnior, A., Arrais, C., Saboya, R. et al. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 41, 95–96 (2008). https://doi.org/10.1038/sj.bmt.1705883
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705883
This article is cited by
-
Cryopreservation method for Drosophila melanogaster embryos
Nature Communications (2021)
-
A Retrospective Analysis of Safety and Efficacy of Wharton’s Jelly Stem Cell Administration in Children with Spina Bifida
Stem Cell Reviews and Reports (2019)
-
Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells
Cell and Tissue Banking (2018)
-
Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion
Bone Marrow Transplantation (2014)
-
Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide
Cell and Tissue Banking (2012)